Citigroup Inc. lowered its position in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 41.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 508,103 shares of the biotechnology company’s stock after selling 361,210 shares during the quarter. Citigroup Inc. owned 0.54% […]
Related Keywords
New York , United States , America , Coherus Biosciences , Dennism Lanfear , Nasdaq , Alphacentric Advisors , Worldwide Group Holding , York Life Investment Management , Exchange Commission , Coherus Biosciences Inc , Citigroup Inc , Barclays , Phocas Financial Corp , Jump Financial , Free Report , Centric Advisors , Get Free Report , Coherus Biosciences Daily , Nasdaq Chrs , Chrs , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,
comparemela.com © 2020. All Rights Reserved.